首页> 美国卫生研究院文献>Taylor Francis Open Select >The UK’s 100000 Genomes Project: manifesting policymakers’ expectations
【2h】

The UK’s 100000 Genomes Project: manifesting policymakers’ expectations

机译:英国的100000个基因组计划:体现政策制定者的期望

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The UK’s 100,000 Genomes Project has the aim of sequencing 100,000 genomes from UK National Health Service (NHS) patients while concomitantly transforming clinical care such that whole genome sequencing becomes routine clinical practice in the UK. Policymakers claim that the project will revolutionize NHS care. We wished to explore the 100,000 Genomes Project, and in particular, the extent to which policymaker claims have helped or hindered the work of those associated with Genomics England – the company established by the Department of Health to deliver the project. We interviewed 20 individuals linked to, or working for Genomics England. Interviewees had double-edged views about the context within which they were working. On the one hand, policymakers’ expectations attached to the venture were considered vacuous “genohype”; on the other hand, they were considered the impetus needed for those trying to advance genomic research into clinical practice. Findings should be considered for future genomes projects.
机译:英国的100,000个基因组计划旨在对来自英国国家卫生局(NHS)患者的100,000个基因组进行测序,同时伴随着临床治疗的转变,以使全基因组测序成为英国的常规临床实践。政策制定者声称,该项目将彻底改变NHS护理。我们希望探索“ 100,000个基因组计划”,尤其是决策者声称在多大程度上帮助或阻碍了与英国基因组学有关的工作-英国基因组学是由卫生部成立的公司,负责执行该项目。我们采访了20位与英国基因组学有联系或在英国工作的人。受访者对他们所处的环境有双重看法。一方面,决策者对合资企业的期望被认为是空洞的“基因型”。另一方面,它们被认为是那些试图将基因组研究推进临床实践的动力。研究结果应考虑用于未来的基因组计划。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号